NCT00615927 Phase II Imatinib + Hydroxyurea in Treatment of Patients With Recurrent/Progressive Grade II Low-Grade Glioma (LGG) Status COMPLETED Phase PHASE2
NCT00613223 Ph I Dose Escalation Trial of Vandetanib in Combo w Etoposide for Malignant Gliomas Status COMPLETED Phase PHASE1
NCT00613132 Ph I Gleevec in Combo w RAD001 + Hydroxyurea for Pts w Recurrent MG Status COMPLETED Phase PHASE1
NCT00613054 Ph I Zactima + Imatinib Mesylate & Hydroxyurea for Pts w Recurrent Malignant Glioma Status COMPLETED Phase PHASE1
NCT00613028 Ph II Bev + Either Temozolomide/Etoposide for GBM Pts Who Have Failed Bev + Irinotecan Status COMPLETED Phase PHASE2
NCT00612989 Ph I 5-day Temozolomide + O6-BG in Treatment of Pts w Recurrent / Progressive GBM Status COMPLETED Phase PHASE1
NCT00612651 PH I Addition of Farnesyl Transferase Inhibitor to Temozolomide for Pts w Gr 3 & 4 Malignant Gliomas Status COMPLETED Phase PHASE1
NCT00612638 Ph. I Temozolomide + O6-BG + Irinotecan in Treatment of Pts w Recurrent / Progressive Cerebral Anaplastic Gliomas Status COMPLETED Phase PHASE1
NCT00612339 Avastin in Combination With Temozolomide for Unresectable or Multifocal GBMs and Gliosarcomas Status COMPLETED Phase PHASE2
NCT00611325 Phase II Avastin + Bortezomib for Patients With Recurrent Malignant Glioma Status COMPLETED Phase PHASE2
NCT00610571 Ph I Oral Topotecan and Temozolomide for Patients With Malignant Gliomas Status COMPLETED Phase PHASE1
NCT00606008 A Phase II Trial of Sutent (Sunitinib; SU011248) for Recurrent Anaplastic Astrocytoma and Glioblastoma Status COMPLETED Phase PHASE2
NCT00597402 Avastin in Combination With Radiation (XRT) & Temozolomide, Followed by Avastin, Temozolomide and Irinotecan for Glioblastoma (GBM) and Gliosarcomas Status COMPLETED Phase PHASE2
NCT00576641 Immunotherapy for Patients With Brain Stem Glioma and Glioblastoma Status COMPLETED Phase PHASE1
NCT00576537 Tumor Lysate Pulsed Dendritic Cell Immunotherapy for Patients With Brain Tumors Status COMPLETED Phase PHASE2
NCT00575887 Efficacy of Protracted Temozolomide in Patients With Progressive High Grade Glioma Status COMPLETED Phase PHASE2
NCT00525525 Study of Bevacizumab Plus Temodar and Tarceva in Patients With Glioblastoma or Gliosarcoma Status COMPLETED Phase PHASE2